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Abstract
Celiac disease (CD) is a systemic, immune‐mediated illness that primarily affects the small 
bowel. A few decades ago, in the era of Watson and Crosby capsules, we used to sample 
the small bowel without even looking at it. Nowadays, with the continuous developing 
field of digestive endoscopy, we can even see the duodenal villi up closely, allowing for 
an optical, real‐time diagnosis of villous atrophy. Advanced endoscopic techniques such 
as magnification, chromoendoscopy (dye‐based and digital), water immersion, confocal 
endomicroscopy, endocytoscopy, and optical coherence tomography (OCT) have been 
evaluated in CD with good results: good agreement with histology, allowing for targeted 
biopsies and a reduction in the number of biopsies needed for diagnosis. Moreover, with 
the growing use of open‐access endoscopy in many parts of the world, endoscopy is now 
contributing to increasing the diagnostic rate of CD, by recognition of endoscopic mark‐
ers in patients without clinical suspicion of this disease. This is however an observer‐
dependent method; to overcome the endoscopists subjectiveness in assessing villous 
atrophy, in the last years, many papers have looked at means of computerized analysis 
of endoscopic images. Currently available data show that these automated, quantitative 
methods hold very promising for the future.
Keywords: celiac disease, advanced endoscopy, capsule endoscopy, computer‐aided, 
diagnosis, endoscopic marker
1. Introduction
Celiac disease (CD) is a systemic autoimmune disease triggered by ingestion of gluten in 
genetically susceptible individuals. Although so much is known about this disease (its trig‐
ger, autoantigen, genetic predisposition, target organ damage, and diet treatment), it remains 
heavily underdiagnosed. In this setting, new diagnostic strategies are being searched for, and 
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great attention has been pointed toward the role of endoscopy in increasing the diagnostic 
rate of celiac disease. Some have even proposed systematic biopsies for patients with abdomi‐
nal pain or reflux symptoms undergoing upper digestive endoscopy, but this has proven to 
have a low yield for diagnosing celiac disease, at a high cost [1–4]. However, with the growing 
use of open‐access endoscopy in many parts of the world, endoscopy can be a great oppor‐
tunity to identify new celiacs, by recognizing suggestive endoscopic markers in previously 
unsuspected patients. The premises for this window of opportunity are a thorough examina‐
tion of the duodenum and appropriate training for the endoscopists to recognize endoscopic 
markers of villous atrophy.
Moreover, endoscopy with tissue sampling is mandatory to establish a correct diagnosis, at 
least in adults [5]. In children, the 2012 ESPGHAN guideline proposed a triple diagnostic 
criteria to avoid biopsy (tissue transglutaminase antibodies over 10 times the upper limit 
of normal, confirmed with positive anti‐endomysial antibodies in a separate blood sample; 
characteristic symptoms of celiac disease; positive HLA‐DQ2/DQ8) [6]. Some studies have 
validated this rule, while others have questioned it [7–10].
But, endoscopy is more than just a mean to get the duodenal mucosal samples. If we think 
back a few decades, in the era of Watson and Crosby capsules, we used to sample the small 
bowel mucosa without even looking at it. Nowadays, with the continuous development of 
technology, endoscopy has turned into a very powerful tool as we can even see the duode‐
nal villi up closely, allowing for an optical, real‐time diagnosis of villous atrophy. Advanced 
endoscopic techniques such as magnification, chromoendoscopy (dye‐based and digital), 
water immersion, confocal endomicroscopy, and optical coherence tomography (OCT) have 
been evaluated in CD with promising results: good agreement with histology, allowing for 
targeted biopsies and a reduction in the number of biopsies needed for diagnosis.
Even more, computer processing of images captured during endoscopy or capsule examina‐
tion have been studied in diagnosing villous atrophy in celiac disease patients. These novel 
computerized methods are based on texture analysis or other image features and offer a quan‐
titative assessment of mucosal atrophy, so that someday maybe they will replace the biopsy.
2. Advanced endoscopic techniques in celiac disease
Diseased small bowel mucosa is often difficult to recognize in standard, white light endos‐
copy. In order to enhance the subtle mucosal abnormalities of celiac disease patients, a spe‐
cial focus has been given to advanced endoscopic techniques: from water immersion and 
dye‐based chromoendoscopy to digital (dyeless) chromoendoscopy, magnification, confocal 
endomicroscopy, endocytoscopy and optical coherence tomography [11, 12]—these have all 
improved the way we macroscopically evaluate the duodenal villous pattern and increased 
the diagnostic accuracy of endoscopy for celiac disease.
Besides better delineation of the subtle mucosal changes compared to standard white light 
endoscopy, these techniques help in accurately characterizing these changes and driving 
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 targeted biopsies. By targeting the most diseased area of the mucosa, use of advanced endo‐
scopic techniques has the potential to reduce the number of biopsies needed for diagnosis, 
or even making a real‐time, in vivo diagnosis of atrophy (the so‐called concept of “virtual” 
biopsy). In vivo histology could be very useful, especially in patients who refuse biopsy and 
keeping in mind the frequent low quality of duodenal biopsy samples. However, most of the 
advanced endoscopy techniques available in daily practice can only assess villous atrophy 
and not the other features of celiac‐type enteropathy (intraepithelial lymphocytosis and crypt 
hyperplasia) and this is considered an issue as villous atrophy can have a wide differential 
diagnosis. Not least, mucosal changes in celiac disease can be patchy and the use of advanced 
endoscopy could be of great help to identify the patchiness and orient biopsy sampling in 
these areas.
The water immersion technique is a simple, quick, and safe method, which can be used rou‐
tinely to enhance the duodenal villous pattern during upper digestive endoscopy (Figures 1 
and 2). Developed by the Italians [13], it consists of two steps: first, suction of the air from the 
duodenal lumen and second, rapid instilling of up to 150 ml water through the channel of 
the scope (either manually by connecting a syringe to the biopsy channel port or by using an 
external water‐pump) [14]. This adds only about 30 sec to a standard examination and has very 
good diagnostic accuracy for villous atrophy (100% sensitivity, 99.7% specificity, 85.7% posi‐
tive predictive value, and 100% negative predictive value for total villous atrophy, and 75, 99.5, 
60, and 99.7%, respectively for partial villous atrophy) [14]. It has a favorable profile regarding 
the tolerability and examiner's learning curve [15]. In a scenario of a biopsy‐avoiding approach, 
Figure 1. Water‐immersion examination of the duodenum showing normal villous pattern.
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using water immersion to diagnose celiac disease has proven to be cost effective [16]. It has 
also been evaluated with good results in cases of villous atrophy limited to the duodenal bulb 
only [17] and in the follow‐up of celiac disease patients to assess histological recovery after 
gluten‐free diet [18]. As we will see in the following paragraphs, water immersion can also be 
used in combination with other techniques (digital chromoendoscopy and magnification) in 
evaluating the duodenal villous pattern.
Dye‐based chromoendoscopy is, as the water‐immersion technique, a simple, inexpen‐
sive method, which can be used to better delineate changes in the mucosal surface of the 
gastrointestinal tract. It consists in topically administering a colorant (methylene blue, 
indigo carmine) over the digestive mucosa, by using a spray catheter. The principle of 
chromoendoscopy is based on the fact that the human eye can better discriminate the con‐
trast given by methylene blue or indigo carmine (which colors the depressed areas of the 
mucosa and highlights the surface pattern) than the red‐pink hue of standard white light 
endoscopy. Its use in examining the mucosa of celiac disease patients dates back in 1976, 
as reported by Stevens [19]. Others have followed with small number of patients [20–25], 
some using combination of chromoendoscopy with magnification, but the most recent 
study on topic comes from the British; 300 patients with no previous history of CD were 
evaluated, with 89/300 (30%) being newly diagnosed celiac disease patients; the authors 
reported an increase of 12% in the identification of endoscopic markers of celiac disease 
with chromoendoscopy vs. white light endoscopy (48/89 meaning 54% vs. 37/89 mean‐
ing 42%, p = 0.001), but the overall diagnostic accuracy was poor compared to serology 
(Table 1) [26].
Figure 2. Water‐immersion examination in a patient with partial villous atrophy.
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Virtual chromoendoscopy is even simpler than dye‐based chromoendoscopy as it only 
requires the press of a button on the scope during the examination to get the desired enhance‐
ment of the digestive mucosa. Therefore, it saves the additional costs needed for dye spraying 
and avoids the prolonged procedure time that comes with conventional chromoendoscopy. 
To get the maximum from a chromoendoscopy examination, the recommendation is to use 
premedication with an antispasmodic and antifoaming agent and to record images during 
the examination (for later analysis). Some of the currently available technologies (see Table 2) 
are based on using electronically activated filters to select certain wavelengths, others use 
post‐processing of images.
Most studies have used narrow band imaging (NBI) (Figure 3) and i‐Scan to better visualize 
the duodenal mucosa. In the study of Singh et al. [27], NBI performed very good in identify‐
ing villous atrophy—93.3% sensitivity and 97.8% specificity (with k values for interobserver 
and intraobserver agreement of 0.82 and 0.86, respectively) and also in discriminating partial 
from total villous atrophy (83.3% sensitivity and 100% specificity, k at 0.73 and 0.68, respec‐
tively). Even better results have been reported with the combination of NBI and magnification 
in the study of De Luca [28], with 100% sensitivity, 92.6% specificity, 95% accuracy, and kappa 
0.9 when compared to histology (detecting partial villous atrophy in 12 patients which was 
missed by standard endoscopy). In the paper of Valitutti et al., when combined with water 
immersion, NBI showed a diagnostic sensitivity of 87.5% with high interobserver agreement 
(k 0.884) [29]. The Indian experience of Dutta and Goswami has also shown good diagnostic 
performance for NBI with sensitivity of 87.5 and 95% and specificity of 95.2 and 90.2%, respec‐
tively [30, 31]. Goswami even proposed a NBI classification of villous pattern—NBI type I for 
normal finger‐like villi, type II for short and stubby villi (cerebriform pattern), type III for 
patchy villous atrophy, and type IV for flat mucosa, without villi.
Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%)
Standard endoscopy 42 98 90 80
Chromoendoscopy 54 97 89 83
Table 1. Diagnostic accuracy of chromoendoscopy in celiac disease [26].
Scope company Chromoendoscopy technology
Olympus (Tokyo, Japan) Narrow band imaging (NBI)
Autofluorescence imaging (AFI)
Pentax (Tokyo, Japan) i‐Scan (surface enhancement/SE, contrast enhancement/
CE, tone enhancement/TE)
Fujifilm (Tokyo, Japan) Flexible spectral imaging color enhancement (FICE)
Fujifilm (Kanagwa, Japan) Blue laser imaging (BLI)
Karl Storz (Tuttlingen, Germany) Storz professional image enhancement system (SPIES)
Table 2. Currently available digital chromoendoscopy technologies.
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For the i‐Scan technology, Cammarota reported accuracy of 100% for detection of marked 
villous atrophy and 90% for partial villous atrophy and normal villous pattern [32]. Strong 
correlation with histology (r = 0.732) and high sensitivity (96%) was obtained by Iacucci by 
combining i‐Scan with water immersion [33]. In a comparative study with or without i‐Scan, 
Penny et al. concluded that it is the high definition endoscopy that increases the detection of 
celiac disease during routine endoscopy, irrespective of the use or not of i‐Scan [34].
Good results have also been reported with flexible spectral imaging color enhancement (FICE), 
on small numbers of patients—100% accuracy in evaluation of villous patterns (marked vil‐
lous atrophy, partial villous atrophy, and normal villi) [35].
Not least, digital chromoendoscopy techniques such as NBI can be used to detect patchy vil‐
lous atrophy (Figure 4) [36].
Magnification or zoom endoscopy allows the endoscopist to get high‐resolution, magnified 
images (up to 135×) in real time (Figure 5), which undoubtedly outperforms the standard 
endoscopy in assessing the villous pattern [15, 37]. It has been studied in combination with 
other techniques—water immersion, chromoendoscopy, and acetic acid instillation (“ace‐
towhitening”’ or enhanced magnification endoscopy), with very good results (see Table 3) 
[37–42]. It is also been shown to be useful in detecting patchy celiac disease [43]. However, 
contrasting these supporting results, the study by Kiesslich et al. [21], on assessing duodenal 
abnormalities (not necessarily focusing on villous atrophy) by dye staining and magnifica‐
tion, the latter did not further increase the diagnostic yield of chromoendoscopy.
Figure 3. Normal villous pattern, endoscopy with narrow band imaging (Olympus, Tokyo, Japan).
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By using a multimodal approach (standard esogastroduodenoscopy combined with zoom 
and chromoendoscopy), some authors have even proposed an endoscopic classification of 
celiac disease (types 0, I, II, and III), with good correlation between the endoscopic changes 
and the histologic findings (reported as Marsh grade) [44].
Confocal laser endomicroscopy (CLE) was first introduced in practice in 2004 by the team 
of Ralf Kiesslich (Mainz, Germany). CLE is based on integrating a confocal microscope in 
the distal tip of a conventional scope, which illuminates the mucosa with a 488 nm wave, 
allowing for cellular‐level imaging (1000× magnification) up to 250 µm in depth. By offering 
mucosal architectural and cellular details, CLE is considered a method of in vivo histology, 
thus offering so‐called virtual or optical biopsies. Currently, CLE can be done either with a 
dedicated scope, which has the confocal scanner integrated into the tip of the scope (inte‐
grated or endoscope‐based CLE, eCLE, or iCLE—available from Pentax, Tokyo, Japan) or by 
using miniprobes which fit into the working channel of the scope (probe‐based CLE, pCLE—
available from Cellvizio Endomicroscopy System; Mauna Kea Technologies, Paris, France) 
[45]. Irrespective of the method used, CLE requires contrast agents, the most commonly 
used being intravenous fluorescein and topical acriflavine. Because image acquisition during 
CLE examination is greatly artefacted by peristalsis, respiratory, and circulatory movements 
(especially in the upper GI tract), the procedure usually consists in capturing the images and 
analyzing them after.
In addition to the advanced endoscopic techniques previously discussed, CLE also allows 
for assessment of crypt hyperplasia and intraepithelial lymphocytosis, which brings it closer 
Figure 4. Patchy loss of villi pattern, endoscopy with narrow band imaging (Olympus, Tokyo, Japan).
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to histology when considering all the features of celiac‐type enteropathy and not only vil‐
lous atrophy. Therefore, it can provide a real‐time, full diagnosis of celiac disease (avoiding 
time and cost of processing and difficulty in interpreting biopsy samples), as shown in a case 
report by Trovato [46]. Furthermore, CLE overcomes the disadvantage of nonrepresentative 
biopsies of conventional endoscopy by allowing targeted biopsies to relevant mucosal areas 
[47].
As shown by Zambelli et al., the images acquired by CLE are similar to those obtained by 
histology, in both normal and celiac disease patients, with best visibility and quality for epi‐
thelial architecture and less for inflammatory infiltrate and crypt [48].
Experience of CLE in celiac disease is not very large; three studies have shown good diagnos‐
tic performance compared to histopathology—sensitivity of 100, 94, and 73%, specificity of 
80, 92 and, 100%, respectively [49–51]. In the study by Leong et al., CLE achieved an excellent 
AUROC (receiver operator characteristics area under the curve) of 0.946. It is worth mention‐
ing that the CLE has a limited ability to evaluate the crypt depth, as Gunther reported modest 
agreement with histology for crypt hyperplasia (sensitivity 52%, compared to 74% for vil‐
lous atrophy and 81% for intraepithelial lymphocytosis). In the same study by Gunther, high 
interobserver agreement was seen for all three histologic features of celiac disease.
Despite being a very valuable tool, the use of CLE is limited in clinical practice because it 
is very time consuming, and it is burdened by a high cost of the equipment and need for 
training.
Figure 5. Magnification image of normal, finger‐shaped duodenal villi.
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Author, year Technique used Sensitivity (%) Specificity (%) Positive predictive value Negative predictive value
Banerjee, 2007 Magnification endoscopy 100 91 83 100
Siegel, 1997 Magnification 
endoscopy + indigo 
carmine‐chromoendoscopy
94 88
Badreldin, 2005 Zoom endoscopy (115×) 90.7 62.9 83 77.2
Cammarota, 2004 Magnification endoscopy 95 99 95 99
Magnification endoscopy 
+ water‐immersion 
technique
95 98 92 99
Lo, 2007 Magnification endoscopy 
+ acetic acid instillation 
(enhanced magnification 
endoscopy)
100 – – –
Table 3. Summary of studies evaluating magnification endoscopy in the detection of villous atrophy [38–42].
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Optical coherence tomography (OCT) combines the ultrasound and infrared technologies, 
and is mostly known for its use in ophthalmology. With OCT, we get 1.5 mm in‐depth exami‐
nation of the digestive mucosa, and the images generated resemble closely the histological 
architecture. Studies done by Masci et al. have shown 100% concordance with histology in 
both diseased and normal individuals, also with good discrimination between the various 
degrees of villous atrophy [52–54].
Endocytoscopy is another novel endoscopic technique that allows in vivo, real‐time visual‐
ization of mucosa under 450× magnification, by using a high power objective lens. Similar 
to CLE, it is also available as probe‐based and endoscope‐based equipment and it requires 
placing the scope/probe in contact with the mucosa to generate images [55]. The study of 
Matysiak‐Budnik et al. on 16 celiac disease patients and seven non‐celiac controls have found 
good concordance between endocytoscopy imaging and conventional histology [56]. The 
method is not used in daily practice.
Capsule endoscopy is a non‐invasive, but expensive method to examine the small bowel. 
With 8× magnification lens and the ability to capture images at a rate up to 6 frames/second, 
capsule endoscopy is an excellent method to evaluate the villous pattern. It is usually reserved 
for special situations, mainly where there is suspicion of refractory or complicated celiac dis‐
ease (malignancy and ulcerative jejunitis). However, it can also be used as a diagnostic tool 
for patients unwilling or unable to undergo upper GI endoscopy or to assess the extent of 
small bowel involvement [57]. Theoretically, it could be also used to search for villous atro‐
phy in seropositive patients with normal histology on duodenal biopsy, although the study 
by Lidums et al. does not support this [58]; however, in a small case series, celiac disease was 
diagnosed on the basis of changes visualized by capsule endoscopy, when upper digestive 
endoscopy and biopsy were unable to provide a diagnosis [59].
As shown in several studies (Table 4), capsule endoscopy has high accuracy in recognizing 
endoscopic markers of villous atrophy, but its major drawback is the lack of possibility for 
tissue sampling, which is currently the cornerstone for adult celiac disease diagnosis. Also, 
another limitation is the need to get training in order to get proficient in this technique. Not 
least, although it has the highest specificity for detecting total villous atrophy in celiac disease 
patients (Table 4), it performs less well in partial villous atrophy [57].
Author, year Sensitivity (%) Specificity (%) Positive predictive 
value (%)
Negative predictive 
value (%)
Petroniene, 2005 70 100 100 77
Hopper, 2007 85 100 100 88.9
Rondonot, 2007 87.5 90.9 96.5 71.4
Biagi, 2007 93.6 63.6 100 77
Maiden, 2009 67 100 100 60
Lidums, 2011 93 100 100 89
Table 4. Summary of studies evaluating the diagnostic accuracy of capsule endoscopy in the detection of villous atrophy 
[60–64].
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Enteroscopy has changed the way we think of the small bowel—if a few decades ago, we 
thought of it as unreachable beyond the limited examination possible during upper and lower 
GI endoscopy, with the latest technology, we are now confident that we can do an extensive 
evaluation of the small bowel. The advantage over capsule endoscopy is that enteroscopy 
allows for tissue sampling and therapy.
Main indications for enteroscopy are patients with positive serology but normal or equivo‐
cal findings in duodenal biopsies [65] and patients with suspected refractory or complicated 
celiac disease [66, 67].
As capsule endoscopy, enteroscopy should be considered as a complementary method in the 
diagnosis and management of celiac disease.
All in all, there is strong evidence for the use of advanced endoscopic techniques in the evalu‐
ation of the duodenal mucosal pattern (Table 5), as it brings several benefits: improving detec‐
tion of mucosal changes (especially in the setting of partial villous atrophy, where endoscopic 
markers are not that evident), delineating their extent, identification of patchy disease, and 
targeting biopsies. This latter aspect allows for a reduction in number of biopsies needed 
for diagnosis by focusing on relevant mucosal areas and it could be of great significance to 
optimize the endoscopic evaluation, as several studies have shown low compliance with the 
currently recommended number of biopsies [68, 69].
As some of these techniques are readily available, being just a press of a button away, endos‐
copists should be trained to use them routinely. Besides equipment costs and training, another 
major limitation of these techniques is that while they are very accurate in detecting villous 
atrophy, most of them cannot establish the full extent of histologic injury, as they cannot asses 
for intraepithelial lymphocytes and crypt hyperplasia. For techniques that offer in vivo histol‐
ogy, solid expertise and histological knowledge is mandatory.
Author, year Endoscopic tool Sensitivity (%) Specificity (%) Positive 
predictive value 
(%)
Negative 
predictive value 
(%)
Oxentenko, 2002 Standard endoscopy 59 92 – –
Cammarota, 2004 Water immersion 90.9 99.5 83.3 99.7
Johnson, 2014 Chromoendoscopy 54 97 89 83
Singh, 2010 NBI 93.3 97.8 93.6 96.7
Iaccuci, 2016 i‐Scan + immersion 96 63 – –
Banerjee, 2007 Magnification 
endoscopy
100 91 83 100
Lo, 2007 Enhanced 
magnification 
endoscopy
96 – – –
Table 5. Summary of studies evaluating the diagnostic performance of various endoscopic techniques in the detection of 
villous atrophy [14, 26, 27, 33, 38, 42, 78].
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3. Endoscopic markers in celiac disease
Over the time, several endoscopic features suggestive of villous atrophy have been described, 
and many studies have investigated their diagnostic accuracy for celiac disease. The endo‐
scopic markers described in celiac disease are [70–73]:
• mucosal atrophy, with visible submucosal vascular pattern (Figure 6),
• mosaic appearance (Figure 7),
• nodular pattern of the mucosa (Figure 8),
• presence of mucosal fissures (grooves), leading to a “cracked‐mud” appearance (Figures 9 
and 10),
• reduction or complete loss of folds in the distal duodenum (Figure 11), and
• scalloping or a dented aspect of the Kerckring folds (Figure 12).
Figure 6. Standard endoscopy showing atrophic mucosa of the duodenal bulb.
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Figure 7. Mosaic pattern of the duodenal mucosa.
Figure 8. Fine nodular pattern of the duodenal mucosa.
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Erosions in the duodenum have also been described in celiac disease, but they are more fre‐
quently related to peptic injury or non‐steroidal anti‐inflammatory drug use [74].
Studies assessing the diagnostic performance of aforementioned markers have shown highly 
variable results, with sensitivity ranging from 6 to 96.7% and specificity from 83 to 100% [75]. 
This could be explained by the heterogeneity of the studies regarding inclusion criteria, the 
subjectiveness of the examiners in evaluating the endoscopic markers, and by the different 
pre‐test probability of having celiac disease (as reported in comparative studies with low‐ and 
high‐risk groups) [76, 77].
Because of the conflicting results of studies investigating the diagnostic accuracy of these 
endoscopic markers, one cannot rely on their presence or absence to decide whether to do or 
not to do biopsies in case of suspected celiac disease. Current recommendation is to perform 
biopsies when there is clinical suspicion of celiac disease, regardless of the presence of endo‐
scopic markers [73], although some proposed that owing to their high negative predictive 
value, biopsy avoidance could be accepted with a normally appearing duodenum on careful 
examination in a low‐prevalence population [77].
Figure 9. Standard endoscopy showing fissuring of the mucosa.
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Another point is that such endoscopic markers are usually described and searched for in the 
distal duodenum, while bulb changes are frequently neglected [78]—this could be a major 
pitfall in the practice of endoscopists, especially in light of recent evidence about ultrashort 
celiac disease (meaning celiac disease with histopathologic changes limited to the duodenal 
bulb only) [79]. In our paper on this issue [75], we evaluated both the duodenal bulb and the 
distal duodenum with respect to the presence of endoscopic markers. We have shown high 
specificity for scalloping, mosaic pattern and fissures, concordant to results of others who 
even stated that a normal duodenum, with the absence of scallops or grooves, excludes subto‐
tal villous atrophy [80]. Scalloping was reported to be a reliable endoscopic marker for celiac 
disease from the study of Kasirer also [81].
Figure 10. Mucosal fissuring seen with NBI (Olympus, Tokyo, Japan).
Figure 11. Loss of folds in the distal duodenum.
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At the opposite, reduction in number or loss of folds had a low diagnostic yield, as Niveloni 
et al. also reported and explained it by the subjectiveness of the endoscopists in the evalua‐
tion of folds (interobserver agreement 0.41 compared to 0.76 for mosaic pattern and 0.83 for 
scalloping) [82]. This finding is supported by the paper of Reyes et al., who stated that reduc‐
tion or loss of folds are not reliable unless other endoscopic features are also present [77]. On 
the other hand, Maurino et al. had previously found the opposite—the changes in folds were 
both sensitive and specific for celiac disease [83]. Regarding the number of markers detected 
during endoscopy, we found that the presence of two or more markers performed well in 
predicting celiac disease, with an AUROC (under the curve receiver operating characteristics) 
of 0.885 [75].
Another issue of these endoscopic markers is that they are present in case of marked vil‐
lous atrophy, but are usually absent in milder degrees of atrophy (such as Marsh 3a), nonde‐
structive enteropathy (Marsh 1 or 2, meaning infiltrative and hyperplastic enteropathy) or in 
patchy disease. It has been shown that prevalence of endoscopic markers is lower in partial 
villous atrophy than subtotal or total villous atrophy (58 vs. 82%) [84]. This is an additional 
argument, why a no‐biopsy strategy, with an apparently normal duodenum, is not feasible.
Also, endoscopic markers are not always that obvious on a gross examination of the duode‐
num, so that use of novel endoscopic techniques such as chromoendoscopy may be useful to 
detect these markers by enhancing the subtle changes in the duodenal mucosal pattern. As 
shown in the study by Niveloni et al., use of chromoendoscopy better delineated the endo‐
scopic markers but did not provide any additional diagnostic yield; however, dye staining 
improved the interobserver agreement for some of the endoscopic markers (folds changes—k 
at 0.41 in standard endoscopy, 0.59 with chromoendoscopy) [82]. Other authors have even 
proposed a key role for these advanced endoscopic techniques in the decision to perform tis‐
sue sampling; according to them, biopsy should be done only in patients with villous atrophy 
detected by image‐enhancing endoscopic techniques; however, they also acknowledge that 
this would miss Marsh 1 patients [85].
Figure 12. Scalloping of the duodenal mucosa.
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In summary, recognition of endoscopic markers during routine endoscopy could represent 
a great opportunity to increase the diagnostic rate of celiac disease. In the era of open‐access 
endoscopy, this incidental action to detect unsuspected celiac disease patients could have a 
significant diagnostic impact [86]. Careful examination of the duodenum is needed to detect 
endoscopic markers of villous atrophy, which should trigger the endoscopist to do biopsies. 
As shown by Castro et al., detection of endoscopic markers is associated with a high probabil‐
ity of diagnosing celiac disease (15.6 positive likelihood ratio) [87], so they should be atten‐
tively searched for, especially in high‐risk patients.
However, absence of endoscopic markers does not rule out celiac disease. Not doing biopsies 
in a normal‐appearing duodenum is associated with a significant miss rate [88]. On the other 
hand, excessive biopsies without any clinical, laboratory workup or endoscopy‐guided selec‐
tion of patients could represent an unnecessary burden to both endoscopists and pathologists. 
The best approach to maximize the diagnostic rate with limiting unnecessary biopsies is to 
use a prediction model that combines pre‐endoscopic with endoscopic findings [88].
Not least, one should keep in mind that detection of villous atrophy on endoscopy does not 
necessarily imply celiac disease, as the differential is very wide (peptic injury, infectious enter‐
opathy, common variable immune deficiency, collagenous sprue, autoimmune enteropathy, 
drug‐induced enteropathy, and eosinophilic enteropathy) [89].
4. Computer‐aided diagnosis in celiac disease
During routine examinations, analysis of endoscopy images to detect villous atrophy can be 
quite difficult because of peristalsis, and presence of luminal foam and bubbles; also, mucosal 
changes are frequently subtle and are not so easy to spot in the above‐mentioned conditions. 
In the last years, great attention has been paid to processing and analyzing of images captured 
during endoscopy (especially capsule endoscopy), with regard to several image‐related char‐
acteristics, in evaluating celiac disease patients. The strong point of using such techniques 
is that it provides a quantitative, automated evaluation compared to the subjectiveness of 
assessing the presence of endoscopic markers of villous atrophy—it thus eliminates the 
interobserver bias reported for other techniques [90].
First studies on this matter looked at the texture, brightness, and motility of the small bowel 
in videoclips from videocapsule examinations of celiac disease patients and controls [91–94].
Later, Ciaccio et al. converted the original images from capsule endoscopy in grayscale and 
performed an automated histogram analysis, with good results in discriminating celiac dis‐
ease patients from controls [95]. An interesting feature was that of using shape‐from‐shading 
modeling to assess the architecture of the mucosa, which was validated by the same group 
of Ciaccio et al. [96]—the number of villous protrusions/image was statistically significant 
lower in celiacs versus controls (p < 0.0001). Other methods tested for the quantitative, com‐
puterized assessment of villous atrophy in celiac disease are the degree of fissuring [97] and 
spectral analysis [98]. They even proposed that such quantitative, automated analysis of the 
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structural features of the mucosa could be done in real time and displayed as a score during 
endoscopy [99].
Other research groups have also studied some advanced image processing techniques (wave‐
lets, feature vectors, and distortion correction) in optimizing the computer‐aided diagnosis of 
celiac disease [100–102]. However, these methods are not yet ready for current practice.
But, although histology is the current gold standard in diagnosing celiac disease, computer‐
aided diagnosis holds very promising for the future. Such computerized methods have been 
studied on imaging from non‐treated celiacs at endoscopy, capsule, and even confocal laser 
endomicroscopy [103]. Compared to an endoscopy + histology approach, which is invasive, 
costly, time‐consuming and subject to interobserver variability, a computer‐based decision 
strategy is less invasive, time‐sparing, and observer independent. Even in the current biopsy‐
based diagnostic approach, computer‐assisted image analysis could be useful by helping 
endoscopists to target the areas with significant mucosal alterations, which would be other‐
wise difficult to detect. Not least, the result of using such computational means is numeric, 
which makes it more accurate in differentiating pathology from normal and in monitoring 
patients on a gluten‐free diet. They need however to be validated in larger cohorts and in 
gluten‐free–treated celiac disease patients. Also, strong collaboration with image engineer‐
ing techs should be developed in order to optimize descriptors for image processing in celiac 
disease [104, 105].
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